UK government agrees to secure supply of 90 million vaccines developed by US company

UK government agrees to secure supply of 90 million vaccines developed by US company August 15 6:32

On the 14th, the British government announced that it agreed to receive 90 million doses in total if two types of new coronavirus vaccines being developed by US pharmaceutical giants are successfully developed ..

According to the British government, if successful development, the US biotechnology company Novavax has agreed to supply 60 million doses of vaccine, and the US drug giant Johnson & Johnson has agreed to supply 30 million doses. ..

Among them, Novabux plans to manufacture some vaccines at a facility of Fujifilm's subsidiary in the UK, and the British government says that if vaccines are available, they will be available promptly.

If both vaccines are successfully developed, they will be supplied to the UK in the middle of next year, so the government will give priority to vaccinations to healthcare workers and the elderly.

In addition to this, the British government has already secured four types of vaccines, including a vaccine being developed by Oxford University in the country and the major pharmaceutical company AstraZeneca.

Several new coronavirus vaccines being developed in each country are in the stage of clinical trials to confirm their safety and efficacy, but the United States and EU = European Union etc. The competition between them is intensifying.

EU also secures supply from US and UK companies

On the other hand, the EU = European Union also announced that by the 14th, if the US drug giant and the UK drug giant each succeeded in developing a vaccine, they would have agreed to receive a total of 500 million doses. did.

The breakdown is 200 million doses from the US pharmaceutical giant Johnson & Johnson and 300 million doses from the British pharmaceutical giant AstraZeneca.

The company also agreed to receive an additional 300 million doses from both companies if more vaccines are needed.

The EU has already agreed with French pharmaceutical giant Sanofi to supply vaccines for 300 million doses, and as a result of this agreement, the EU has secured vaccines for three types in total and a maximum of 1.1 billion doses. Will be.

EU Chairman Von de Alien issued a statement yesterday that "it can be offered not only to Europeans, but to any partner in the world," and will adapt the vaccine to countries outside the EU depending on the situation. Showed an idea.